NCT06054399

Brief Summary

Patient education is one type of low-cost intervention that can be easily applied but there are not specific studies about it in pregnant women with migraine. The primary goal of the study is to educate pregnant women experiencing migraine, leading to their understanding of the underlying pathology, management strategies and alarm symptoms. An intervention based on education can lead to empowered individuals capable of self-management, therefore reducing medication overuse and inappropriate use of the emergency department. It is relevant that these patients have access to understandable information; that is, in their own language and avoiding complex medical terms, so that the information can be useful for them and their support system. With this project the investigators aimed to improve the knowledge and satisfaction of participants (patients and healthcare professionals) to better deal with migraines during pregnancy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 5, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

September 26, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2025

Completed
Last Updated

September 28, 2023

Status Verified

September 1, 2023

Enrollment Period

1.9 years

First QC Date

September 5, 2023

Last Update Submit

September 25, 2023

Conditions

Keywords

migrainepregnancy

Outcome Measures

Primary Outcomes (2)

  • Improvement in Migraine Disability Assessment questionnaire score

    The Migraine Disability Assessment questionnaire will be apply to patients, both at their first prenatal appointment and at the end of their postpartum period (up to 42 days postpartum), to evaluate the level of pain and the impact of headache on their daily life.The questionnaire comprises 7 questions in total and the score ranges between 0 to 90, higher scores mean higher grade of disability.

    8 to 9 months

  • Improvement in Brief Illness Perception questionnaire score

    Both at their first prenatal appointment and at the end of their postpartum period (up to 42 days postpartum), the Brief Illness Perception questionnaire, to evaluate cognitive and emotional representation of illness.This questionnaire comprises 8 items and the score ranges from 0 to 80, a higher score indicates a greater perceived psychological burden of illness.

    8 to 9 months

Secondary Outcomes (1)

  • Obstetricians Assessment

    9 months

Study Arms (1)

Audiovisual educational intervention

EXPERIMENTAL

Audiovisual educational intervention will be apply within 3 moments of the pregnancy pf patients.

Other: educational program

Interventions

Education resources in Spanish through social media directed to the targeted audience mentioned above. There will be at least three interventions along the study, one for each pregnancy trimester, including topics such as: Migraine criteria, management strategies, risks of medication overuse, alarm symptoms, etc. These educational interventions will be conducted by trained health care professionals, mainly using audio-visual media.

Audiovisual educational intervention

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant women 18 years or older with migraine according to clinical criteria
  • Informed Consent signed
  • Controlled during its pregnancy at Clínica Alemana de Santiago

You may not qualify if:

  • Any impossibility to complete the follow-up during postpartum period.
  • Language barriers that would impede the patient to understand the applied questionnaires and educational interventions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinica Alemana de Santiago

Santiago, Santiago Metropolitan, Chile

Location

MeSH Terms

Conditions

Migraine Disorders

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Veronica V Olavarria, MD, MSC

    Clinica Alemana de Santiago

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Veronica V Olavarria, MD, MSC

CONTACT

Veronica V Olavarria, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
All the participants will know about the educational interventional as well as their physicians.
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: before and after quasi experimental
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

September 5, 2023

First Posted

September 26, 2023

Study Start

December 1, 2023

Primary Completion

October 31, 2025

Study Completion

November 30, 2025

Last Updated

September 28, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations